Beneficial and rapid effect of infliximab on the course of toxic epidermal necrolysis

Acta Dermato-Venereologica

Volumn 88, Issue 4, 2008, Pages 420-421

  Wojtkiewicz, Agnieszka ^a   Wysocki, Mariusz ^a   Fortuna, Jacek ^a   Chrupek, Malgorzata ^a   Matczuk, Maciej ^a   Koltan, Andrzej ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; COTRIMOXAZOLE; DEXAMETHASONE; IMMUNOGLOBULIN G; INFLIXIMAB;

ADOLESCENT; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; EAR INFECTION; FEMALE; FOLLOW UP; HUMAN; LABORATORY TEST; LETTER; PRIORITY JOURNAL; SINGLE DRUG DOSE; SINUSITIS; THERAPY EFFECT; TOXIC EPIDERMAL NECROLYSIS; TREATMENT OUTCOME;

ADOLESCENT; ANTIBODIES, MONOCLONAL; DERMATOLOGIC AGENTS; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; HUMANS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 47749091698     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0462     Document Type: Letter

References (9)

1. Hunger RE, Hunziker T, Buettiker U, Braathen LR, Yawalkar N. Rapid resolution of toxic epidermal necrolysis with anti-TNF-alpha treatment. J Allergy Clin Immunol 2005; 116: 923-924.
2. Chave TA, Mortimer NJ, Sladden MJ, Hall AP, Hutchinson PE. Toxic epidermal necrolysis: current evidence, practical management and future directions. Br J Dermatol 2005; 153: 241-253. Comment in: Br J Dermatol 2006; 155: 842-843.
3. Fischer M, Fiedler E, Marsch WC, Wohlrab J. Antitumour necrosis factor-alpha antibodies (infliximab) in the treatment of a patient with toxic epidermal necrolysis. Br J Dermatol 2002; 146: 707-709.
4. Gupta AK, Skinner AR. A review of the use of infliximab to manage cutaneous dermatoses. J Cutan Med Surg 2004; 8: 77-89.
5. Lissia M, Figus A, Rubino C. Intravenous immunoglobulins and plasmapheresis combined treatment in patients with severe toxic epidermal necrolysis: preliminary report. Br J Plast Surg 2005; 58: 504-510.
6. Faye O, Roujeau JC. Treatment of epidermal necrolysis with high-dose intravenous immunoglobulins (IVIg): clinical experience to date. Drugs 2005; 65: 2085-2090.
7. Karduan SH, Jonkman MF. Dexamethasone pulse therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis. Acta Derm Venereol 2007; 87: 144-148.
8. Al-Shouli S, Abouchala N, Bogusz MJ, Al Tufail M, Thestrup-Pedersen K. Toxic epidermal necrolysis associated with high intake of sildenafil and its response to infliximab. Acta Derm Venereol 2005; 85: 534-535.
9. Meiss F, Helmbold P, Meykadeh N, Gaber G, Marsch WCh, Fischer M. Overlap of acute generalized exanthematous pustulosis and toxic epidermal necrolysis: response to antitumour necrosis factor-alpha antibody infliximab: report of three cases. J Eur Acad Dermatol Venereol 2007; 21: 717-719.